Compare GKOS & TXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GKOS | TXT |
|---|---|---|
| Founded | 1998 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 14.5B |
| IPO Year | 2015 | N/A |
| Metric | GKOS | TXT |
|---|---|---|
| Price | $115.81 | $90.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 12 |
| Target Price | ★ $126.38 | $92.33 |
| AVG Volume (30 Days) | 694.2K | ★ 1.4M |
| Earning Date | 10-29-2025 | 01-21-2026 |
| Dividend Yield | N/A | ★ 0.09% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.55 |
| Revenue | $469,820,000.00 | ★ $14,237,000,000.00 |
| Revenue This Year | $31.15 | $8.63 |
| Revenue Next Year | $24.15 | $4.98 |
| P/E Ratio | ★ N/A | $19.82 |
| Revenue Growth | ★ 30.38 | 1.83 |
| 52 Week Low | $73.16 | $57.70 |
| 52 Week High | $163.71 | $91.22 |
| Indicator | GKOS | TXT |
|---|---|---|
| Relative Strength Index (RSI) | 71.98 | 68.66 |
| Support Level | $115.07 | $85.62 |
| Resistance Level | $117.94 | $91.22 |
| Average True Range (ATR) | 2.91 | 1.60 |
| MACD | -0.13 | 0.41 |
| Stochastic Oscillator | 81.29 | 86.92 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Textron is a conglomerate that designs, manufactures, and services a range of specialty aircraft including small jets, propeller-driven airplanes, helicopters, and tilt-rotor aircraft. Textron Aviation manufactures and services Cessna and Beechcraft planes. Bell is a helicopter and tilt-rotor manufacturer and servicer for both commercial and military customers. Textron Systems produces uncrewed aircraft and armored vehicles for the military market as well as aircraft simulators and training for the commercial and military markets. Textron Industrial contains the Kautex business, which manufactures plastic fuel tanks for conventional and hybrid motor vehicles, and other subsidiaries that produce specialized vehicles such as golf carts and all-terrain vehicles.